232 related articles for article (PubMed ID: 28738683)
1. State prescription drug monitoring programs and fatal drug overdoses.
Nam YH; Shea DG; Shi Y; Moran JR
Am J Manag Care; 2017 May; 23(5):297-303. PubMed ID: 28738683
[TBL] [Abstract][Full Text] [Related]
2. Implications of prescription drug monitoring and medical cannabis legislation on opioid overdose mortality.
Phillips E; Gazmararian J
J Opioid Manag; 2017; 13(4):229-239. PubMed ID: 28953315
[TBL] [Abstract][Full Text] [Related]
3. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
4. Prescription drug monitoring programs and drug overdose deaths involving benzodiazepines and prescription opioids.
Liang D; Shi Y
Drug Alcohol Rev; 2019 Jul; 38(5):494-502. PubMed ID: 31317593
[TBL] [Abstract][Full Text] [Related]
5. Measuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid Overdoses.
Cerdá M; Ponicki WR; Smith N; Rivera-Aguirre A; Davis CS; Marshall BDL; Fink DS; Henry SG; Castillo-Carniglia A; Wintemute GJ; Gaidus A; Gruenewald PJ; Martins SS
Epidemiology; 2020 Jan; 31(1):32-42. PubMed ID: 31596794
[TBL] [Abstract][Full Text] [Related]
6. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.
Martins SS; Ponicki W; Smith N; Rivera-Aguirre A; Davis CS; Fink DS; Castillo-Carniglia A; Henry SG; Marshall BDL; Gruenewald P; Cerdá M
Int J Drug Policy; 2019 Dec; 74():174-180. PubMed ID: 31627159
[TBL] [Abstract][Full Text] [Related]
7. Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses: A Systematic Review.
Fink DS; Schleimer JP; Sarvet A; Grover KK; Delcher C; Castillo-Carniglia A; Kim JH; Rivera-Aguirre AE; Henry SG; Martins SS; Cerdá M
Ann Intern Med; 2018 Jun; 168(11):783-790. PubMed ID: 29801093
[TBL] [Abstract][Full Text] [Related]
8. Do more robust prescription drug monitoring programs reduce prescription opioid overdose?
Pardo B
Addiction; 2017 Oct; 112(10):1773-1783. PubMed ID: 28009931
[TBL] [Abstract][Full Text] [Related]
9. A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016.
Smith N; Martins SS; Kim J; Rivera-Aguirre A; Fink DS; Castillo-Carniglia A; Henry SG; Mooney SJ; Marshall BDL; Davis C; Cerdá M
Addiction; 2019 Feb; 114(2):248-258. PubMed ID: 30207015
[TBL] [Abstract][Full Text] [Related]
10. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
[TBL] [Abstract][Full Text] [Related]
11. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
12. Association of Prescription Drug Monitoring Programs With Opioid Prescribing and Overdose in Adolescents and Young Adults.
Toce MS; Michelson KA; Hudgins JD; Hadland SE; Olson KL; Monuteaux MC; Bourgeois FT
Ann Emerg Med; 2023 Apr; 81(4):429-437. PubMed ID: 36669914
[TBL] [Abstract][Full Text] [Related]
13. Surveillance, Self-Governance, and Mortality: The Impact of Prescription Drug Monitoring Programs on U.S. Overdose Mortality, 2000-2016.
Vuolo M; Frizzell LC; Kelly BC
J Health Soc Behav; 2022 Sep; 63(3):337-356. PubMed ID: 35001700
[TBL] [Abstract][Full Text] [Related]
14. Opportunities to Prevent Overdose Deaths Involving Prescription and Illicit Opioids, 11 States, July 2016-June 2017.
Mattson CL; O'Donnell J; Kariisa M; Seth P; Scholl L; Gladden RM
MMWR Morb Mortal Wkly Rep; 2018 Aug; 67(34):945-951. PubMed ID: 30161105
[TBL] [Abstract][Full Text] [Related]
15. Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity.
Brown R; Riley MR; Ulrich L; Kraly EP; Jenkins P; Krupa NL; Gadomski A
Drug Alcohol Depend; 2017 Sep; 178():348-354. PubMed ID: 28692945
[TBL] [Abstract][Full Text] [Related]
16. Prescription drug monitoring program design and function: A qualitative analysis.
Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
[TBL] [Abstract][Full Text] [Related]
17. Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.
Martins SS; Sampson L; Cerdá M; Galea S
Am J Public Health; 2015 Nov; 105(11):e29-49. PubMed ID: 26451760
[TBL] [Abstract][Full Text] [Related]
18. Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.
Martins SS; Sampson L; Cerdá M; Galea S
Am J Public Health; 2015 Nov; 105(11):2373. PubMed ID: 26451757
[TBL] [Abstract][Full Text] [Related]
19. Prescription drug monitoring and dispensing of prescription opioids.
Brady JE; Wunsch H; DiMaggio C; Lang BH; Giglio J; Li G
Public Health Rep; 2014; 129(2):139-47. PubMed ID: 24587548
[TBL] [Abstract][Full Text] [Related]
20. Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings.
Pauly NJ; Slavova S; Delcher C; Freeman PR; Talbert J
Drug Alcohol Depend; 2018 Mar; 184():26-32. PubMed ID: 29402676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
